HBK Investments’s Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share CLAA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-67,500
Closed -$28K 717
2022
Q1
$28K Sell
67,500
-2,600
-4% -$1.3K ﹤0.01% 600
2021
Q4
$50K Buy
+70,100
New +$56.4K ﹤0.01% 625

Other funds holding CLAA.WS

HBK Investments's CLAA.WS Position: Q2 2022 in Review

HBK Investments sold out of Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share (CLAA.WS) in Q2 2022, closing a stake of 67,500 shares — an estimated $28K sold.

HBK Investments first reported a position in CLAA.WS in Q4 2021 and held it in 2 quarters. The position peaked at $50K in Q4 2021. 42 funds tracked by Wall St. Rank hold CLAA.WS as of Q2 2022.

  • HBK Investments reported no remaining Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position as of Q2 2022 after selling out during the quarter.
  • HBK Investments sold 67,500 Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share shares in Q2 2022, an estimated $28K.
  • HBK Investments first reported a position in Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in Q4 2021 and held it in 2 quarters.
  • HBK Investments's Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position peaked at $50K in Q4 2021.
  • 42 funds tracked by Wall St. Rank held Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share as of Q2 2022.

Based on HBK Investments's 13F filing for Q2 2022, filed 15 Aug 2022.